Wolfe Research Downgrades Abbvie (ABBV) to Peerperform
Tweet Send to a Friend
Wolfe Research analyst Alexandria Hammond downgraded Abbvie (NYSE: ABBV) from Outperform to Peerperform.The analyst comments "We're downgrading ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


